Funding Events for Vertical: Biopharmaceuticals
← Back to All Verticals
Loading funding events...
Company Name | Funding Type | Date Awarded | Vertical |
---|---|---|---|
PhorMed | Equity | March 26, 2022 | Biopharmaceuticals |
BioCurity Pharmaceuticals | Equity | March 25, 2020 | Biopharmaceuticals |
Bluejay Therapeutics | Series C | May 09, 2024 | Biopharmaceuticals |
BioCurity Pharmaceuticals Inc. | Equity | January 01, 2024 | Biopharmaceuticals |
RS BioTherapeutics | Convertible Notes | April 24, 2024 | Biopharmaceuticals |
Amlogenyx Inc. | Seed | August 02, 2024 | Biopharmaceuticals |
Idrx | Series B | August 07, 2024 | Biopharmaceuticals |
Paradigm Therapeutics | Series A | May 16, 2025 | Biopharmaceuticals |
NLS Pharma | Equity Financing | May 17, 2025 | Biopharmaceuticals |
Idorsia | Debt Restructuring | May 18, 2025 | Biopharmaceuticals |
BioVersys AG | IPO | January 29, 2025 | Biopharmaceuticals |
Helicore Biopharma | Series A | January 28, 2025 | Biopharmaceuticals |
Takeda | Grant | May 19, 2025 | Biopharmaceuticals |
Kailera Therapeutics | Series A | January 04, 2025 | Biopharmaceuticals |
AsclepiX Therapeutics Inc. | Series A | June 24, 2020 | Biopharmaceuticals |
Arrivo BioVentures LLC | Venture | May 26, 2016 | Biopharmaceuticals |
3-V Biosciences | Series D | January 05, 2015 | Biopharmaceuticals |
AusperBio | Series B | December 27, 2024 | Biopharmaceuticals |
Akarna Therapeutics | Series B | February 16, 2016 | Biopharmaceuticals |
BlackThorn Therapeutics | Series A | October 21, 2016 | Biopharmaceuticals |